Study evaluates factors associated with racial disparities in colon cancer screening

Blacks and Hispanics appear less likely to undergo colorectal cancer screening than whites because of socioeconomic, health care access and language barriers, according to a report in the June 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, other factors may contribute to screening disparities experienced by Asians.

Colorectal cancer screening rates lag behind those for other cancer screening tests, according to background information in the article. In addition, marked disparities appear to exist between non-Hispanic whites and racial and ethnic minorities in the United States. "Such disparities in screening may contribute to the higher colorectal cancer incidence and mortality [death] rates observed in racial/ethnic minorities relative to non-Hispanic whites," the authors write.

Anthony F. Jerant, M.D., and colleagues at the University of California Davis School of Medicine, Sacramento, analyzed data from two national surveys conducted between 2000 and 2005. A total of 22,973 adults age 50 and older answered questions about demographics, colorectal cancer screening behaviors and other social and health care factors.

Overall, 54.1 percent of the participants were screened for colorectal cancer using either colonoscopy or fecal occult blood testing (FOBT). Individuals in racial and ethnic minority groups were less likely than whites to be tested—33.8 percent of Asians, 48.2 percent of blacks and 36.7 percent of Hispanics underwent a screening procedure, compared with 57.2 percent of whites.

After adjusting for other factors associated with screening behavior—including demographics, socioeconomic variables, language spoken at home, health care access and self-rated health—disparities between blacks, Hispanics and whites disappeared, the authors note. "Beyond socioeconomic factors, which disproportionately affect minorities, these findings suggest the effect of access and, for Hispanics, language-appropriate care on colorectal cancer screening uptake," they write.

However, after adjusting for the same factors, disparities between whites and Asians remained significant. "Although this study does not permit firm conclusions regarding the reason for this finding, the implication is that unmeasured cultural factors may contribute to the Asian/non-Hispanic white disparity in colorectal cancer screening," the authors write. "Less acculturated Asian individuals in the United States may have core health beliefs and values that differ from those in the 'Western' health model, leading them to decline FOBT or endoscopy offered in the absence of worrisome symptoms. They may also be less likely to be offered colorectal cancer screening."

The findings suggest that different types of programs may improve screening rates in separate minority groups, the authors conclude. Culturally targeted interventions for patients and physicians may help address Asian individuals, enhancing access to health care may help mitigate disparities between white and black patients and maximizing access and offering language-appropriate care and information may increase the number of Hispanics who are screened.

Source: JAMA and Archives Journals

Related stories:

Just a numbers game? Making sense of health statistics
Presidential candidates use them to persuade voters, drug companies use them to sell their products, and the media spin them in all kinds of ways, but nobody - candidates, reporters, let alone health consumers - understands them. Health statistics fill today's information environment, but even most doctors, who must make daily decisions and recommendations based on numerical data - for instance, to calculate the risks of a certain drug or surgical intervention, or to inform a patient of the possible benefits versus harms of cancer screening - lack the basic statistical literacy they require to make such decisions effectively.
Study shows stool DNA testing for colorectal cancer has potential, but challenges remain
The first generation of a stool DNA test to identify early colorectal cancer has limitations, according to a Mayo Clinic-led study published in the Oct. 7, 2008, issue of Annals of Internal Medicine. Results did not corroborate findings of an earlier multicenter study that showed stool DNA testing was more accurate than fecal blood testing for colorectal cancer detection. *
New study examines effectiveness of colorectal cancer screening tests
New findings from a Decision Analysis for the US Preventative Services Task Force (USPSTF) suggest that routine colorectal cancer screenings can be stopped in patients over the age of 75. The results are based on patients who began screenings at age 50 and have had consistently negative screenings up to the age of 75. Lead author Ann Graham Zauber, PhD, Associate Attending Biostatistician in the Department of Epidemiology and Biostatistics at Memorial Sloan-Kettering Cancer Center and her colleagues' findings are published in the October 7, 2008 online edition of Annals of Internal Medicine and will appear in a forthcoming issue.

CRC screening before Medicare age could save millions in federal health-care dollars
A screening program for colon cancer in patients starting ten years prior to Medicare eligibility, at age 55 instead of Medicare's 65, would save at least two dollars for every dollar spent, according to a new study presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando.
Metabolic syndrome ups colorectal cancer risk
In a large U.S. population-based study presented at the 73rd Annual Scientific Meeting of the American College of Gastroenterology, metabolic syndrome patients had a 75 percent higher risk of colorectal cancer compared to those without metabolic syndrome.
Most adults under 50 unlikely need colorectal screening
Young adults without a family history of bowel disease are unlikely to develop adenomas, the colorectal polyps most likely to lead to cancer, according to new research directed by scientists at the Johns Hopkins Kimmel Cancer Center. The finding supports current cancer screening guidelines recommending adults in general undergo screening colonoscopies starting at age 50.
Colon cancer link to obesity uncovered
A new study reveals the first-ever genetic link between obesity and colon cancer risk, a finding that could lead to greater accuracy in testing for the disease, said a researcher at the University of Alabama at Birmingham (UAB).
Black Americans are at higher risk for colon polyps
Black Americans have a higher occurrence of colon polyps, according to a new study. This is a significant finding considering the incidence of colon cancer among black men has increased and remained unchanged among black women during the last 20 years.

News discussion:

Medicine & Health news